NovaBridge Biosciences (NBP) Interest Coverage Ratio (2019 - 2020)
NovaBridge Biosciences (NBP) reported Interest Coverage Ratio of 640834.95 for Q3 2020, down 110934.56% year-over-year from N/an in Q4 2019, and down 1047359.05% quarter-over-quarter from 61.18 in Q4 2019.
NovaBridge Biosciences (NBP) Interest Coverage Ratio (2019 - 2020) Analysis & Trends
NovaBridge Biosciences (NBP) has 2 years of Interest Coverage Ratio data on file, last reported at 640834.95 in Q3 2020.
- Interest Coverage Ratio for Q3 2020 came in at 640834.95, down 110934.56% year-over-year; the trailing twelve-month figure through Dec 2020 was 139286.13 (changed N/A YoY), and the FY2023 annual result was 359.01, down 100.68% from the prior year.
- Interest Coverage Ratio retreated to 640834.95 in Q3 2020 per NBP's latest filing, from 61.18 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 578.19 in Q3 2019 and troughed at 640834.95 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -258.33 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 11.79 |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -640,834.95 |
| Dec 31, 2019 | -61.18 |
| Sep 30, 2019 | 578.19 |